Canaccord Genuity Maintains a 'Buy' on AngioDynamics (ANGO); Q3 Preview

March 30, 2012 8:40 AM EDT
Get Alerts ANGO Hot Sheet
Price: $15.63 -1.2%

Rating Summary:
    8 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on AngioDynamics (NASDAQ: ANGO) price target of $16.50.

Analyst, Jason R. Mills, said, "ANGO reports FQ3 on April 4, and we expect in-line results (sees $0.07/$50.6mln)...We believe the focus of the call will be on updates to the Navilyst acquisition, which, while dilutive near term has the potential to drive EBITDA upside in out years via revenue and cost synergies."

Mills said that he was unerwhelmed by the Navilyst deal, but the risk/reward is still favorable and suggests investors start building positions in the stock at the $12-13 range.

For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.

Shares of AngioDynamics closed at $12.27 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View